Ipsen acquired OctreoPharm to strengthen its Oncology presence
Ipsen is determined to increase its presence in the oncology field, by acquiring OctreoPharm Sciences.…
20/05/2015 - 2 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
PsiOxus raised €34.7 Million from First-Class investors
PsiOxus Therapeutics has closed a Series C financing round of €34.7M (£25 million) to progress…
19/05/2015 - 2 minutes
Baxter’s spinoff Baxalta is building up its Oncology portfolio
Baxter has purchased Sigma-Tau’s portfolio of cancer treatments for €793.5M ($900 million). With this important…
18/05/2015 - 2 minutes
European companies present their cancer treatment solutions in the USA
Each year, the American Society of Clinical Oncology gathers the cancer therapy developers during five…
15/05/2015 - 3 minutes
Eli Lilly signs a €250M deal with BioNTech for new Cancer Immunotherapies
Using immunotherapy to treat cancer is one of the hottest trends in healthcare research right…
14/05/2015 - 2 minutes
PhoreMost awarded €1.96M to target the “undruggable” Cancer Genes
Cambridge-based PhoreMost has been selected to receive a funding award of €1.96M (£1.4 million) from…
11/05/2015 - 2 minutes
Natural Killer therapies for Cancer: a Fast-Evolving field
Natural killers are an emerging approach to fight inflammatory diseases and cancer. These immune actors,…
05/05/2015 - 3 minutes
A new Microfluidic Chip technology raised €1.9Million
Lunaphore Technologies closed a Series A financing round of €1.9M (CHF 2 millions). The round…
30/04/2015 - 3 minutes
PEP-Therapy Raised €1.3 Million in Seed Capital
France-based PEP-Therapy has raised €1.3M in initial funding. This sum, invested by the Quadrivium 1…
28/04/2015 - 2 minutes
Are personalized treatments for lung cancer underutilized?
Results from a new global survey of lung cancer oncologists have shown that, despite 81%…
23/04/2015 - 3 minutes
OncoBEAM blood test arrives to Europe
Sysmex Inostics have signed an exclusive distributor agreement with IndivuTest, and its parent company Indivumed,…
22/04/2015 - 2 minutes
Erytech Strengthens its Intellectual Property Position in the US
Erytech strengthed its intellectual property portfolio in the United States with the granting of a…
22/04/2015 - 2 minutes
